Endocrinological profiles in patients with prostate cancer treated with LHRH antagonist
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
Price : $35 *
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 12 Oct 2017 Status changed from active, no longer recruiting to completed.
- 08 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by UMIN record.
- 12 Oct 2013 New trial record